How to buy RxSight stock (RxSight)

RxSight is a medical devices business based in the US. RxSight shares (RXST) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $33.66 – a decrease of 9.76% over the previous week. RxSight employs 374 staff and has a trailing 12-month revenue of around $128.3 million.

Our top picks for where to buy Rxsight stock

Buy RxSight stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

RxSight stock price (NASDAQ: RXST)

Use our graph to track the performance of RXST stocks over time.

RxSight shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$33.66
52-week range	$34.92 - $66.54
50-day moving average more info button	$46.62
200-day moving average more info button	$51.76
Wall St. target price	$60.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.81

Is it a good time to buy RxSight stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

RxSight price performance over time

Historical closes compared with the close of $33.66 from 2024-12-20

1 week (2024-12-13)	-9.76%
1 month (2024-11-22)	-24.92%
3 months (2024-09-20)	-36.47%
6 months (2024-06-21)	-40.68%

1 year (2023-12-22)	-15.09%
2 years (2022-12-22)	170.58%
3 years (2021-12-22)	235.59%
5 years (2019-12-18)	N/A

RxSight financials

Revenue TTM	$128.3 million
Gross profit TTM	$21.3 million
Return on assets TTM	-9.92%
Return on equity TTM	-13.99%
Profit margin	-23.92%
Book value	$6.89
Market Capitalization more info button	$1.5 billion

TTM: trailing 12 months

RxSight share dividends

We're not expecting RxSight to pay a dividend over the next 12 months.

You may also wish to consider:

• Procter-and-Gamble Company (PG.US) (2.36% forward annual dividend yield)

RxSight share price volatility

Over the last 12 months, RxSight's shares have ranged in value from as little as $34.92 up to $66.54. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while RxSight's is 1.191. This would suggest that RxSight's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

To put RxSight's beta into context you can compare it against those of similar companies.

• Bausch Health Companies (BHC.US): 0.745
• National Vision (EYE.US): 1.417
• Procter-and-Gamble Company (PG.US): 0.414

RxSight overview

RxSight, Inc. , a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc.

Frequently asked questions

What percentage of RxSight is owned by insiders or institutions?
Currently 5.08% of RxSight shares are held by insiders and 89.501% by institutions. How many people work for RxSight?
Latest data suggests 374 work at RxSight. When does the fiscal year end for RxSight?
RxSight's fiscal year ends in December. Where is RxSight based?
RxSight's address is: 100 Columbia, Aliso Viejo, CA, United States, 92656 What is RxSight's ISIN number?
RxSight's international securities identification number is: US78349D1072